<DOC>
	<DOCNO>NCT01018849</DOCNO>
	<brief_summary>The purpose study determine Vitamin D supplementation help prevent recurrent cardiovascular event , heart attack stroke , patient already experience least one cardiovascular event . This study investigate addition 150,000 international unit cholecalciferol ( vitamin D3 ) mouth every 2 month subject 's medication regimen prevent cardiovascular event .</brief_summary>
	<brief_title>Role Vitamin D Secondary Prevention Cardiovascular Events</brief_title>
	<detailed_description>The purpose study determine Vitamin D supplementation help prevent recurrent cardiovascular event , heart attack stroke , patient already experience least one cardiovascular event . This study investigate addition 150,000 international unit cholecalciferol ( vitamin D3 ) mouth every 2 month subject 's medication regimen prevent cardiovascular event .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Male female age &gt; 19 year time inform consent sign . Subject diagnosis unstable angina ( Thrombolysis Myocardial Infarction ( TIMI ) score great equal 3 ) / NSTEMI STEMI , document coronary artery disease define least one coronary artery &gt; 50 % occlusion Subject able come back clinic follow visit least 1 year enrollment . Subject treatment either phenytoin phenobarbitol orlistat ( since medication may cause vitamin D deficiency ) . Subject need two steroid burst per year comorbid condition ( since steroid may impair vitamin D metabolism ) . Subject investigational drug , new drug class part standard ACS protocol . Subject take supplement vitamin D dose &gt; 400 IU/day . Subject hypersensitivity vitamin D product . Subject history systemic lupus erythematosus ( since vitamin D deficiency common group27 ) . Subject history sarcoidosis ( since hypercalcemia high level vitamin D28 ) Subject history renal stone . Subject hypercalcemia , define serum calcium level &gt; 10.6 mg/dl , time screen . Subject end stage renal disease , define either chronic kidney disease stage V require dialysis ( since patient alter vitamin D calcium metabolism ) . Subject systemic disease ( include terminal cancer , cirrhosis , end stage COPD etc. , ) reduce ( &lt; 12 month ) life expectancy . Subject history psychiatric illness/condition would interfere his/her ability understand complete requirement study . Subject condition opinion investigator place subject unacceptable risk participant study . Subject pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Cardiac Catheterization</keyword>
	<keyword>Cardiovascular event</keyword>
	<keyword>Cardiovascular Disease</keyword>
</DOC>